Kalbe Farma Tbk PT (KLBF)

1,605
+15(+0.94%)
  • Volume:
    66,271,400
  • Bid/Ask:
    1,600/1,605
  • Day's Range:
    1,560 - 1,610

KLBF Overview

Prev. Close
1,590
Day's Range
1,560-1,610
Revenue
25.12T
Open
1,590
52 wk Range
1,240-1,960
EPS
63.87
Volume
66,271,400
Market Cap
75.23T
Dividend (Yield)
28.00
(2.14%)
Average Vol. (3m)
47,740,894
P/E Ratio
24.90
Beta
0.64
1-Year Change
7.43%
Shares Outstanding
46,872,947,110
Next Earnings Date
Nov 29, 2021
What is your sentiment on Kalbe Farma Tbk PT?
or
Market is currently closed. Voting is open during market hours.

Kalbe Farma Tbk PT Company Profile

Employees
12202
Market
Indonesia

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. It operates in four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. The company offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. It also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, pre-teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, the company operates Mitrasana Clinics, a health care service; contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products. Further, it offers health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as provides advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe Farma Tbk. is a subsidiary of PT Gira Sole Prima.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Buy
Technical IndicatorsStrong SellBuyBuyBuyBuy
SummaryNeutralBuyBuyBuyStrong Buy
  • Menurun
    0
    • lets go to buy
      0
      • asing pada akumulasi semua...1800 pasti tercapai segera...sit tight honey
        1
        • Please jangan panic selling. Di situasi seperti skr ini normalnya saham farmasi dan rumah sakit jadi primadona. Stay calm yang udah megang sahamnya.
          0
          • btul, invstor ritel pada panic selling. to skrg udh mulai uptrend..smoga balik ke 1800
            0
        • Baiknya beli ndak gan?
          0
          • beli gan...
            0
        • Baiknya beli ndak gan?
          0
          • beli.besok naik lg..krna udh rebound td di 1535
            0
        • Lagi turun semua
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.